PTM Biolabs

PTM Biolabs, Inc is a world-leading company in developing both pan antibodies and sequence-specific antibodies targeting multiple PTM pathways. Pan antibodies against PTMs are the most difficult reagents to be developed in antibody generation. To date, PTM Biolabs, Inc developed most PTM pan antibodies worldwide, including the well known antibodies... against acetylation, methylation, phosphorylation and the unique antibodies targeting crotonylation, succinylation, propionylation, butyrylation, and more. With the superior PTM antibodies, the identification and characterization of PTMs in epigenetics and the quantification of PTM dynamics in different cellular contexts will be intensively explored. In biomedical and pharmaceutical research, the premium PTM reagents can be applied in enzyme substrates screening, biomarkers and drug targets discovery.Read More